Skip to content

2025 Publications

  • Bellando-Randone S, Wilhalme H, Bruni C, Czirjak L, Distler O, Allanore Y, Cuomo G, Denton C, Del Galdo F, Gheorghiu AM, Riccieri V, Walker U, Truchetet ME, Vonk MC, Foeldvari I, Matucci-Cerinic M, Furst DE; and the EUSTAR collaborators. The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort. Arthritis Res Ther. 2025 Mar 27;27(1):66. doi: 10.1186/s13075-025-03476-0. PMID: 40148996; PMCID: PMC11948955. (PDF)
  • Györfi AH, Filla T, Polzin A, Tascilar K, Buch M, Tröbs M, Matei AE, Airo P, Balbir-Gurman A, Kuwert F, Mihai C, Kabala A, Graßhoff H, Callaghan J, Isomura Y, Mansour J, Spierings J, Tennoe AH, Selvi E, Riccieri V, Hoffmann-Vold AM, Bergmann C, Schett G, Hunzelmann N, van Laar JM, Saketkoo LA, Kuwana M, Siegert E, Riemekasten G, Distler O, du Four T, Smith V, Truchetet ME, Distler JHW; EUSTAR collaborators. Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research Cohort. J Am Heart Assoc. 2025 Mar 4;14(5):e036730. doi: 10.1161/JAHA.124.036730. Epub 2025 Feb 26. PMID: 40008525. (PDF)
  • Yan Q, Bruni C, Garaiman A, Mihai C, Jordan S, Becker MO, Elhai M, Dobrota R, Liubov P, Henes J, Hachulla E, Siegert E, Balbir-Gurman A, Cuomo G, Riemekasten G, Heitmann S, Beigi DMR, Ullman S, Sfikakis P, Ingegnoli F, Bernardino V, Truchetet ME, Vonk M, Galdo FD, Hoffmann-Vold AM, Shuang Y, Distler O; EUSTAR collaborators. Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database. Ann Rheum Dis. 2025 Feb 1:S0003-4967(25)00068-8. doi: 10.1016/j.ard.2025.01.014. Epub ahead of print. PMID: 39894689.
  • Bjørkekjær HJ, Bruni C, Broch K, Brunborg C, Carreira PE, Airò P, Simeón-Aznar CP, Truchetet ME, Giollo A, Balbir-Gurman A, Martin M, Denton CP, Gabrielli A, Del Galdo F, Vonk MC, Fretheim H, Bitter H, Midtvedt Ø, Andreassen A, Høie S, Tanaka Y, Riemekasten G, Müller-Ladner U, Matucci-Cerinic M, Castellví I, Siegert E, Hachulla E, Molberg Ø, Distler O, Hoffmann-Vold AM; EUSTAR collaborators. A comparative analysis of risk stratification tools in systemic sclerosis-associated pulmonary arterial hypertension: a EUSTAR analysis. Rheumatology (Oxford). 2025 Jan 29:keaf053. doi: 10.1093/rheumatology/keaf053. Epub ahead of print. PMID: 39878955. (PDF)
  • Roth E, Bruni C, Petelytska L, Becker MO, Dobrota R, Jordan S, Mihai C, Muraru S, Carreira PE, De Vries-Bouwstra J, Braun-Moscovici Y, Liakouli V, Moroncini G, Bergmann C, Mouthon L, Denton CP, De Santis M, Cauli A, Adler S, Bernardino V, Truchetet ME, Vonk M, Del Galdo F, Hoffmann-Vold AM, Distler O, Elhai M; EUSTAR collaborators. Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort. Rheumatology (Oxford). 2025 Jan 8:keaf016. Epub ahead of print. doi: 10.1093/rheumatology/keaf016. PMID: 39775478. (PDF)
  • Velauthapillai A, de Vries-Bouwstra JK, Henes J, Czirjak L, Dagna L, Riemekastan G, Allanore Y, Foti R, Alegre-Sancho JJ, Maurer B, Cuomo G, Spierings J, Martin T, Truchetet ME, van den Ende CH, Vonk MC. Longitudinal association between nailfold capillaroscopy and incident interstitial lung disease: A EUSTAR database analysis. J Scleroderma Relat Disord. 2025 Jan 6:23971983241307692. Epub ahead of print. doi: 10.1177/23971983241307692. PMID: 39777215. (PDF)